SGLT2 Inhibitors Linked to Lower Delirium Risk Compared to Metformin in Type 2 Diabetes Patients Read more about SGLT2 Inhibitors Linked to Lower Delirium Risk Compared to Metformin in Type 2 Diabetes Patients
Study Finds Continuous Glucose Monitoring Feasible During Intensive Hematological Cancer Treatments Read more about Study Finds Continuous Glucose Monitoring Feasible During Intensive Hematological Cancer Treatments
Body Shape and Brain Health: BRI Predicts Cognitive Decline in Women with Type 2 Diabetes Read more about Body Shape and Brain Health: BRI Predicts Cognitive Decline in Women with Type 2 Diabetes
Elevated Colorectal Cancer Risk in Type 2 Diabetes: New Evidence Calls for Early and Sustained Screening Read more about Elevated Colorectal Cancer Risk in Type 2 Diabetes: New Evidence Calls for Early and Sustained Screening